Look who’s talking now
September 3, 2007Medical Communications, Sales and Marketing blog, digi pharma, digital pharma, new media, social networking, technology
The internet loves a good scandal. From compromising celebrity videos to the latest political whisperings, whatever your interest in life, …
Latest news from Datammonitor
August 31, 2007Sales and Marketing
Advanced Life Sciences metastatic melanoma drug granted orphan statusThe FDA has granted orphan drug designation to Advanced Life Sciences for …
GSK’s orphan drug for leukaemia approved
August 30, 2007Sales and Marketing
Atriance, a new treatment for two rare, but deadly, types of blood cancer has been approved in Europe as an …
New blood pressure drug Rasilez approved in Europe
August 30, 2007Sales and Marketing
New high blood pressure medication Rasilez has been approved in Europe, with its marketers Novartis claiming it is the first …
Efficient NHS will stay out of debt, says Johnson
August 30, 2007Health secretary Alan Johnson has confidently predicted that the NHS will not slip back into debt this year – and …
New Rebif formulation approved in Europe
August 30, 2007Sales and Marketing
A new version of multiple sclerosis treatment Rebif, which promises to produce fewer reactions when patients inject it, is to …
Pfizer and BMS to fight fat together
August 29, 2007Research and Development
A new research collaboration between Pfizer and Bristol-Myers Squibb could eventually produce innovative treatments for metabolic diseases including obesity and …
Latest news from Datamonitor
August 28, 2007Research and Development, Sales and Marketing
Alfacell reports promising results for cancer drugAlfacell Corporation has reported the results of a preclinical study showing that its cancer …
The interim: a new kind of manager
August 28, 2007Business Services careers, interim management, recruitment
Interim management has been around since the 1980s, but it has come a long way since then. Twenty years ago, …
Avastin approved as first-line treatment for lung cancer
August 24, 2007Sales and Marketing avastin, lung cancer
Roche's cancer drug Avastin has gained European approval as a first-line treatment for lung cancer on the back of data …
Tysabri wins NICE approval
August 23, 2007Sales and Marketing
NICE has approved Biogen Idec's Tysabri for rapidly evolving severe relapsing/remitting multiple sclerosis (RRMS), using its fast-track, single technology appraisal …
Pfizer appoints new finance chief
August 23, 2007Sales and Marketing Pfizer
Pfizer has appointed Frank D'Amelio as its new head of finance, and says he has a strong track record in …
Patient information high on MHRA agenda
August 22, 2007Medical Communications patients
The MHRA has launched a wide-ranging consultation on its future direction, and improving information for patients is a key topic …
Improve services or lose out to private sector, government warns GPs
August 21, 2007The Department of Health has sent out a strongly-worded warning to England's GPs, telling them they must open in evenings …
Roche unveils Pegasys compliance service
August 21, 2007Medical Communications compliance, patients
Roche has set up a new multimedia service to support patients prescribed its hepatitis C treatment, Pegasys.Roche has been a …
Media buyers Bartlett Davis join ABPI
August 21, 2007ABPI
Bartlett Davis Communications has joined the ABPI, a move that acknowledges the increasing demands its code of practice places on …
Amgen to cut jobs on the back of sales slide
August 20, 2007Sales and Marketing Amgen
Amgen, one of the world's most successful biotech companies is to cut its staff numbers by up to 14% in …
Helping brands see round corners
August 20, 2007Sales and Marketing market research, marketing, sales, survey
Helping brand teams cope with climate changeThis year marked the 50th Anniversary of the Market Research Society. At the MRS …
10 steps to a more effective e-detail
August 20, 2007Medical Communications, Sales and Marketing creativity, e-detailing, marketing
With so many pharma companies still to take up e-detailing, experience of moving along the learning curve is proving to …
News roundup from Datamonitor
August 17, 2007Research and Development, Sales and Marketing
Cel-Sci secures manufacturing facility for Multikine cancer drugCel-Sci has entered into an agreement with a biomedical real estate group under …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
